Literature DB >> 28928142

Role of thyroid hormones in the neoplastic process: an overview.

Iuri Martin Goemann1, Mirian Romitti1, Erika L Souza Meyer2, Simone Magagnin Wajner1, Ana Luiza Maia3.   

Abstract

Thyroid hormones (TH) are critical regulators of several physiological processes, which include development, differentiation and growth in virtually all tissues. In past decades, several studies have shown that changes in TH levels caused by thyroid dysfunction, disruption of deiodinases and/or thyroid hormone receptor (TR) expression in tumor cells, influence cell proliferation, differentiation, survival and invasion in a variety of neoplasms in a cell type-specific manner. The function of THs and TRs in neoplastic cell proliferation involves complex mechanisms that seem to be cell specific, exerting effects via genomic and nongenomic pathways, repressing or stimulating transcription factors, influencing angiogenesis and promoting invasiveness. Taken together, these observations indicate an important role of TH status in the pathogenesis and/or development of human neoplasia. Here, we aim to present an updated and comprehensive picture of the accumulated knowledge and the current understanding of the potential role of TH status on the different hallmarks of the neoplastic process.
© 2017 Society for Endocrinology.

Entities:  

Keywords:  carcinogenesis; iodothyronine deiodinases; neoplasia; thyroid hormone receptors; thyroid hormones

Mesh:

Substances:

Year:  2017        PMID: 28928142     DOI: 10.1530/ERC-17-0192

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  15 in total

1.  Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment.

Authors:  Dotan Moskovich; Yael Finkelshtein; Adi Alfandari; Amit Rosemarin; Tzuri Lifschytz; Avivit Weisz; Santanu Mondal; Harinarayana Ungati; Aviva Katzav; Debora Kidron; Govindasamy Mugesh; Martin Ellis; Bernard Lerer; Osnat Ashur-Fabian
Journal:  Oncogene       Date:  2021-09-23       Impact factor: 9.867

Review 2.  Thyroid hormone signaling in the intestinal stem cells and their niche.

Authors:  Maria Virginia Giolito; Michelina Plateroti
Journal:  Cell Mol Life Sci       Date:  2022-08-10       Impact factor: 9.207

Review 3.  The Clinical Relevance of Hypothyroidism in Patients with Solid Non-Thyroid Cancer: A Tantalizing Conundrum.

Authors:  Maria V Deligiorgi; Dimitrios T Trafalis
Journal:  J Clin Med       Date:  2022-06-14       Impact factor: 4.964

Review 4.  Physiological Role and Use of Thyroid Hormone Metabolites - Potential Utility in COVID-19 Patients.

Authors:  Eleonore Fröhlich; Richard Wahl
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-26       Impact factor: 5.555

5.  Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis.

Authors:  Georgios Kostopoulos; Ioannis Doundoulakis; Christina Antza; Emmanouil Bouras; Krishnarajah Nirantharakumar; Dimitrios Tsiachris; G Neil Thomas; Gregory Y H Lip; Konstantinos A Toulis
Journal:  Endocr Relat Cancer       Date:  2021-04-29       Impact factor: 5.678

6.  Increased expression of the thyroid hormone nuclear receptor TRα1 characterizes intestinal tumors with high Wnt activity.

Authors:  Joel Uchuya-Castillo; Nicolas Aznar; Carla Frau; Pierre Martinez; Clementine Le Nevé; Laetitia Marisa; Luiz O F Penalva; Pierre Laurent-Puig; Alain Puisieux; Jean-Yves Scoazec; Jacques Samarut; Stephane Ansieau; Michelina Plateroti
Journal:  Oncotarget       Date:  2018-07-24

Review 7.  Involvement of Thyroid Hormones in Brain Development and Cancer.

Authors:  Gabriella Schiera; Carlo Maria Di Liegro; Italia Di Liegro
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

Review 8.  Recent Advances in Thyroid Hormone Regulation: Toward a New Paradigm for Optimal Diagnosis and Treatment.

Authors:  Rudolf Hoermann; John E M Midgley; Rolf Larisch; Johannes W Dietrich
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-22       Impact factor: 5.555

9.  Decreased expression of the thyroid hormone-inactivating enzyme type 3 deiodinase is associated with lower survival rates in breast cancer.

Authors:  Iuri Martin Goemann; Vicente Rodrigues Marczyk; Mariana Recamonde-Mendoza; Simone Magagnin Wajner; Marcia Silveira Graudenz; Ana Luiza Maia
Journal:  Sci Rep       Date:  2020-08-17       Impact factor: 4.379

10.  Thyroid dysfunction and breast cancer risk among women in the UK Biobank cohort.

Authors:  Thi-Van-Trinh Tran; Camille Maringe; Sara Benitez Majano; Bernard Rachet; Marie-Christine Boutron-Ruault; Neige Journy
Journal:  Cancer Med       Date:  2021-05-26       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.